TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia

[1]  Kevin F. Bieniek,et al.  C9ORF72 repeat expansions in cases with previously identified pathogenic mutations , 2013, Neurology.

[2]  L. Petrucelli,et al.  Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study , 2013, The Lancet Neurology.

[3]  B. Boeve,et al.  TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia , 2013, Journal of neurochemistry.

[4]  E. Kremmer,et al.  The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS , 2013, Science.

[5]  Kevin F. Bieniek,et al.  Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS , 2013, Neuron.

[6]  O. Brady,et al.  The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function. , 2013, Human molecular genetics.

[7]  Rosa Rademakers,et al.  How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders? , 2012, Current opinion in neurology.

[8]  J. Trojanowski,et al.  TMEM106B, the Risk Gene for Frontotemporal Dementia, Is Regulated by the microRNA-132/212 Cluster and Affects Progranulin Pathways , 2012, The Journal of Neuroscience.

[9]  Jin-A Lee,et al.  The functional analysis of the CHMP2B missense mutation associated with neurodegenerative diseases in the endo-lysosomal pathway. , 2012, Biochemical and biophysical research communications.

[10]  E. Kremmer,et al.  Membrane Orientation and Subcellular Localization of Transmembrane Protein 106B (TMEM106B), a Major Risk Factor for Frontotemporal Lobar Degeneration*♦ , 2012, The Journal of Biological Chemistry.

[11]  Janel O. Johnson,et al.  Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study , 2012, The Lancet Neurology.

[12]  Bruce L. Miller,et al.  Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.

[13]  David Heckerman,et al.  A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.

[14]  R. Aebersold,et al.  Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations , 2011, Nature Cell Biology.

[15]  J. Trojanowski,et al.  A harmonized classification system for FTLD-TDP pathology , 2011, Acta Neuropathologica.

[16]  Y. Ye,et al.  The p97 ATPase associates with EEA1 to regulate the size of early endosomes , 2011, Cell Research.

[17]  J. Morris,et al.  Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels. , 2011, Archives of neurology.

[18]  D. Neary,et al.  Frontotemporal lobar degeneration genome wide association study replication confirms a risk locus shared with amyotrophic lateral sclerosis , 2011, Neurobiology of Aging.

[19]  William T. Hu,et al.  Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis , 2011, Acta Neuropathologica.

[20]  K. Sleegers,et al.  TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort , 2011, Brain : a journal of neurology.

[21]  D. Geschwind,et al.  TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers , 2010, Neurology.

[22]  C. van Broeckhoven,et al.  Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations , 2010, Human molecular genetics.

[23]  M. J. Fresnadillo Martínez,et al.  Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions , 2010, Nature Genetics.

[24]  S. Young,et al.  ESCRT-III Dysfunction Causes Autophagosome Accumulation and Neurodegeneration , 2007, Current Biology.

[25]  S. Melquist,et al.  Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. , 2006, Human molecular genetics.

[26]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[27]  C. Duijn,et al.  Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.

[28]  S. Melquist,et al.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.

[29]  J. Trojanowski,et al.  Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations , 2008, Acta Neuropathologica.

[30]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .